Insider Transactions Reported by 19 Insiders of Bicara Therapeutics Inc.

Symbol
BCAX on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Bicara Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $108,854,468 +$39,999,780 +58% 26 Feb 2026
Kiran Mazumdar-Shaw Director, 10%+ Owner $83,184,246 09 Jun 2025
Biocon Ltd 10%+ Owner $73,155,178 16 Sep 2024
TPG GP A, LLC Former 10% Owner $25,962,692 16 Sep 2024
James E. Flynn Possible Members of 10% Group, 10%+ Owner $23,774,208 17 Sep 2024
FMR LLC Other* $14,770,801 16 Sep 2024
FIL Ltd Other* $13,426,861 16 Sep 2024
Claire Mazumdar Chief Executive Officer, Director $6,504,787 -$2,556,108 -28% 09 Mar 2026
Ryan Cohlhepp President and COO, Director $3,944,020 -$2,297,008 -37% 16 Mar 2026
Ivan Hyep Chief Financial Officer $2,652,089 -$1,514,829 -36% 03 Mar 2026
David Raben Chief Medical Officer $1,024,045 -$916,618 -47% 03 Mar 2026
Nils Lonberg Director $397,183 09 Jun 2025
Kate Haviland Director $98,491 09 Jun 2025
Lara Meisner Chief Legal Officer $0 -$845,625 -100% 02 Feb 2026
Jake Simson Director 09 Jun 2025
Michael Powell Director 09 Jun 2025
Christopher Bowden Director 09 Jun 2025
Carolyn Ng Director 12 Sep 2024
Scott M. Robertson Director 09 Jun 2025

Recent Insider Transactions by Companies or Individuals for Bicara Therapeutics Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Ryan Cohlhepp BCAX Common Stock Sale -5.86% $245,714 $19.66 -12,500 200,641 16 Mar 2026 Direct
Ryan Cohlhepp BCAX Common Stock Options Exercise 3.9% 8,000 213,141 16 Mar 2026 Direct
Ryan Cohlhepp BCAX Stock Option (Right to Buy) Options Exercise -6.38% -8,000 117,334 16 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Sale -9.77% $704,657 $19.17 -36,766 339,392 09 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Options Exercise 10.8% 36,766 376,158 09 Mar 2026 Direct
Claire Mazumdar BCAX Stock Option (Right to Buy) Options Exercise -16.1% -36,766 191,107 09 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Sale -1.11% $71,572 $18.75 -3,817 339,392 06 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Options Exercise 1.12% 3,817 343,209 06 Mar 2026 Direct
Claire Mazumdar BCAX Stock Option (Right to Buy) Options Exercise -1.65% -3,817 227,873 06 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Sale -0.52% $33,464 $18.74 -1,786 339,392 05 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Options Exercise 0.53% 1,786 341,178 05 Mar 2026 Direct
Claire Mazumdar BCAX Stock Option (Right to Buy) Options Exercise -0.76% -1,786 231,690 05 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Sale -0.77% $49,289 $18.73 -2,631 339,392 04 Mar 2026 Direct
Claire Mazumdar BCAX Common Stock Options Exercise 0.78% 2,631 342,023 04 Mar 2026 Direct
Claire Mazumdar BCAX Stock Option (Right to Buy) Options Exercise -1.11% -2,631 233,476 04 Mar 2026 Direct
Ivan Hyep BCAX Common Stock Sale -2% $54,062 $18.25 -2,963 145,355 04 Mar 2026 Direct
Ivan Hyep BCAX Common Stock Options Exercise 2.04% 2,963 148,318 04 Mar 2026 Direct
Ivan Hyep BCAX Stock Option (Right to Buy) Options Exercise -3.58% -2,963 79,784 04 Mar 2026 Direct
David Raben BCAX Common Stock Sale -22.8% $301,920 $18.52 -16,300 55,286 04 Mar 2026 Direct
David Raben BCAX Common Stock Options Exercise 29.5% 16,300 71,586 04 Mar 2026 Direct
David Raben BCAX Stock Option (Right to Buy) Options Exercise -23.6% -16,300 52,913 04 Mar 2026 Direct
Ryan Cohlhepp BCAX Common Stock Sale -7.82% $315,893 $18.16 -17,392 205,141 03 Mar 2026 Direct
Ryan Cohlhepp BCAX Common Stock Options Exercise 6.15% 12,892 222,533 03 Mar 2026 Direct
Ryan Cohlhepp BCAX Stock Option (Right to Buy) Options Exercise -9.33% -12,892 125,334 03 Mar 2026 Direct
Ivan Hyep BCAX Common Stock Sale -8.53% $246,910 $18.22 -13,555 145,355 03 Mar 2026 Direct
Ivan Hyep BCAX Common Stock Options Exercise 9.33% 13,555 158,910 03 Mar 2026 Direct
Ivan Hyep BCAX Stock Option (Right to Buy) Options Exercise -18.9% -13,555 58,144 03 Mar 2026 Direct
David Raben BCAX Common Stock Sale -0.36% $3,690 $18.45 -200 55,286 03 Mar 2026 Direct
David Raben BCAX Common Stock Options Exercise 0.36% 200 55,486 03 Mar 2026 Direct
David Raben BCAX Stock Option (Right to Buy) Options Exercise -0.29% -200 69,213 03 Mar 2026 Direct
Ra Capital Management, L.P. BCAX Common Stock Purchase 6.97% $4,800,000 $16.00 300,000 4,603,418 26 Feb 2026 See footnotes
Ra Capital Management, L.P. BCAX Pre-Funded Warrant (Right to Buy) Purchase 2,200,000 2,200,000 26 Feb 2026 See Footnotes
Ryan Cohlhepp BCAX Common Stock Sale -1.7% $65,501 $18.04 -3,631 209,641 25 Feb 2026 Direct
Ryan Cohlhepp BCAX Common Stock Options Exercise 1.48% 3,108 213,272 25 Feb 2026 Direct
Ryan Cohlhepp BCAX Stock Option (Right to Buy) Options Exercise -2.2% -3,108 138,226 25 Feb 2026 Direct
Ryan Cohlhepp BCAX Stock Option (Right to Buy) Award 300,000 300,000 02 Feb 2026 Direct
Claire Mazumdar BCAX Stock Option (Right to Buy) Award 450,000 450,000 02 Feb 2026 Direct
David Raben BCAX Stock Option (Right to Buy) Award 100,000 100,000 02 Feb 2026 Direct
Ivan Hyep BCAX Stock Option (Right to Buy) Award 125,000 125,000 02 Feb 2026 Direct
Lara Meisner BCAX Stock Option (Right to Buy) Award 90,000 90,000 02 Feb 2026 Direct
Ryan Cohlhepp BCAX Common Stock Sale -1.79% $69,296 $18.10 -3,828 210,164 22 Jan 2026 Direct
Ivan Hyep BCAX Common Stock Sale -1.28% $34,162 $18.15 -1,882 145,355 22 Jan 2026 Direct
Ivan Hyep BCAX Common Stock Options Exercise 1.29% 1,882 147,237 22 Jan 2026 Direct
Ivan Hyep BCAX Stock Option (Right to Buy) Options Exercise -2.79% -1,882 65,462 22 Jan 2026 Direct
Ryan Cohlhepp BCAX Common Stock Sale -0.07% $2,685 $18.02 -149 213,992 15 Jan 2026 Direct
Ryan Cohlhepp BCAX Common Stock Options Exercise 13.2% 25,000 214,141 26 Dec 2025 Direct
Ryan Cohlhepp BCAX Stock Option (Right to Buy) Options Exercise -38.5% -25,000 39,909 26 Dec 2025 Direct
David Raben BCAX Common Stock Options Exercise 55.8% 19,789 55,286 26 Dec 2025 Direct
David Raben BCAX Stock Option (Right to Buy) Options Exercise -16.7% -19,789 98,987 26 Dec 2025 Direct
Ivan Hyep BCAX Common Stock Sale -5.95% $168,492 $18.31 -9,200 145,355 22 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.